News
The DWTS alum shared a post on Instagram, in which she addressed speculation about her appearance, including rumors that ...
The morbidly obese members of the so-called National Association to Advance Fat Acceptance (NAAFA) have predictably come out ...
It’s no secret that obesity is becoming an epidemic in the United States. It’s estimated that by 2030, 50 percent of ...
Apple Fitness Plus is one of CNET’s favorite workout apps thanks to its versatility and various exercise selections. It's affordable at only $11 a month, giving you access to thousands of workouts for ...
Doctors and many patients say GLP-1 drugs can help solve the growing problem of obesity. But some bristle at the thought that ...
As the cost of Mounjaro jabs is set to increase by as much as 170 per cent, Jade Kay, who has already spent £2.4k on the drug ...
An Iowa pharmacy that has been sued by business partners for millions of dollars is now being sanctioned by the state for distributing counterfeit Ozempic.
Uncover the truth about GLP-1 weight loss drugs like Ozempic and Mounjaro. Learn how they work, who benefits most, potential risks, and why experts say they can be game-changing tools for fighting ...
Glucagon-like peptide 1 receptor agonists, including semaglutide, have increased in use and will continue to increase due to their effectiveness in weight loss.
She recommends women undergo a “baseline” dual-energy X-ray absorptiometry (DEXA) scan in their early to mid-30s to help ...
By Brooke Hudspeth, Pharm.D. University of Kentucky You’ve likely heard about glucagon-like peptide-1 agonists – usually ...
The agency shared information from reports by users of compounded semaglutide and tirzepatide who have experienced health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results